AMX0014, meanwhile, is a calpain-2-targeting antisense drug, in late preclinical development, with an initial clinical trial due to start before year-end. “Our pipeline is supported by ...

六、相关文献 [1] Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003 Oct;83(4):731-801. [2] Sorimachi H, Imajoh - Ohmi S, Emori Y, Kawasaki H, Suzuki K. Molecular cloning and ...